机译:骨髓树突状细胞衍生的微囊泡,用于肿瘤的联合免疫化学疗法
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China;
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China;
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China;
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China;
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China;
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China;
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China;
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China;
Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China|Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430030, Hubei, Peoples R China|Huazhong Univ Sci & Technol, Hubei Engn Res Ctr Novel Drug Delivery Syst, Wuhan 430030, Hubei, Peoples R China;
cancer; chemotherapy; dendritic cells; immunotherapy; microvesicles;
机译:鼠骨髓源性树突状细胞的协同组合载有全肿瘤裂解物和全身化疗介导抗肿瘤免疫应答体内
机译:同种异体骨髓内骨髓移植,供体淋巴细胞输注和树突状细胞联合免疫治疗恶性肿瘤
机译:表达诱导性多能干细胞衍生的肿瘤相关抗原的树突状细胞(DC)的抗肿瘤免疫应答:与骨髓来源的DC相比
机译:从藻酸盐水凝胶中释放的钙在体外使骨髓来源的树突状细胞成熟
机译:骨髓源性树突状细胞免疫后CD8 + T细胞反应的特征。
机译:幼年和老年大鼠骨髓间充质干细胞微泡中差异表达的microRNA及其对HK2细胞中肿瘤生长因子-β1介导的上皮-间质转化的影响
机译:表达诱导多能干细胞的肿瘤相关抗原的树突细胞(DCS)的抗肿瘤免疫响应:与骨髓衍生的DC相比
机译:表征和靶向骨髓衍生的炎症细胞驱动儿童星形细胞脑肿瘤的恶性和进展。